Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 464545

Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas


Glavas-Obrovac, Ljubica,; Vladika, Ivan,; Stefanic, Mario; Suver, Mirjana; Mihaljevic, Ivan
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas // 22th Annual Congress of the European Association of Nuclear Medicine – EANM’09
Barcelona, Španjolska, 2009. (poster, nije recenziran, sažetak, znanstveni)


CROSBI ID: 464545 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas

Autori
Glavas-Obrovac, Ljubica, ; Vladika, Ivan, ; Stefanic, Mario ; Suver, Mirjana ; Mihaljevic, Ivan

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
22th Annual Congress of the European Association of Nuclear Medicine – EANM’09

Mjesto i datum
Barcelona, Španjolska, 10.10.2009. - 14.10.2009

Vrsta sudjelovanja
Poster

Vrsta recenzije
Nije recenziran

Ključne riječi
Activin A ; Inhibin A ; Thyroid Papillary and Follicular Carcinomas

Sažetak
Aim: To determine clinical implications of activin A (ActA), inhibin A (InhA), and their receptors ActRI and ActRIIB mRNA expression profile testing in papillary (PTC) and follicular (FTC) thyroid carcinoma. Methods: Tissue samples were divided in 6 groups: 27 PTC, 21 FTC, 11 Hürthle cell carcinomas (HC), 16 follicular adenomas (FA), 15 Hürthle cell adenomas (HA) and 26 euthyroid multinodular goiters (MNG). RNA was isolated from 10-μm paraffin tissue sections. Gene expression was studied using reverse transcription-polymerase chain reaction (RT-PCR). An internal control gene was HPRT1. ImageQuantTL program was used for relative quantification of RT-PCR bands. Data, expressed as medians (interquartile ranges), were processed using Kruskall-Wallis test with Schaich- Hamerle post-hoc analysis. Results: InhA, ActA and ActRI, but not ActRIIB mRNA, were expressed in the majority of tissue samples. InhA mRNA was over- expressed in HA relative to FA (P=0.00044), FTC (P=10-3) and PTC (P=2.9x10-5). HC were indistinguishable from HA, as well as FTC from FA. In contrast, InhA mRNA was consistently overexpressed in Hürthle cell neoplasms when compared to follicular variants [181 (142-205) vs. 89 (70-112), HA vs. FA, P=5.5x10-5 and 164 (115- 176) vs. 98 (81-107), % HPRT1 mRNA, HC vs. FTC, P=7.9x10-5]. Moreover, InhA mRNA was over- expressed in metastatic PTC (n=10) relative to non-metastatic forms [99 (92-117) vs. 84 (76-88), % HPRT1 mRNA, pN0 vs pN1+, P=0.007] ; no other differences were observed between PTC, FTC and MNG. Additionally, ActRI mRNA expression was down- regulated in FA, FTC and PTC relative to MNG (P=1.8x10-5, 6.8x10-4 and 3.3x10-4), whereas ActA mRNA was under-expressed in PTC relative to FA and, marginally, HC (P=2.3x10-3and 8.6x10-3). Neither pT stage, nor age were related to mRNA expression in cancerous tissue specimens. Conclusion: Activin system is involved in the maintenance of homeostasis in normal and transformed thyrocytes: InhA, ActA and the activin signaling pathway are differentially affected by cell transformation over a broad spectrum of neoplastic phenotypes and may play role in thyroid tumorigenesis. Here, we implicate InhA mRNA expression as a possible marker of PTC aggressiveness, metastatic potential and progression.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
219-2192190-2182 - Osobitosti koštane pregradnje u bolesnika s urolitijazom (Milas-Ahić, Jasminka, MZOS ) ( CroRIS)

Ustanove:
Klinički bolnički centar Osijek,
Akademija medicinskih znanosti,
Medicinski fakultet, Osijek,
Sveučilište J. J. Strossmayera u Osijeku


Citiraj ovu publikaciju:

Glavas-Obrovac, Ljubica,; Vladika, Ivan,; Stefanic, Mario; Suver, Mirjana; Mihaljevic, Ivan
Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas // 22th Annual Congress of the European Association of Nuclear Medicine – EANM’09
Barcelona, Španjolska, 2009. (poster, nije recenziran, sažetak, znanstveni)
Glavas-Obrovac, Ljubica, , Vladika, Ivan, , Stefanic, M., Suver, M. & Mihaljevic, I. (2009) Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas. U: 22th Annual Congress of the European Association of Nuclear Medicine – EANM’09.
@article{article, author = {Stefanic, Mario and Suver, Mirjana and Mihaljevic, Ivan}, year = {2009}, keywords = {Activin A, Inhibin A, Thyroid Papillary and Follicular Carcinomas}, title = {Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas}, keyword = {Activin A, Inhibin A, Thyroid Papillary and Follicular Carcinomas}, publisherplace = {Barcelona, \v{S}panjolska} }
@article{article, author = {Stefanic, Mario and Suver, Mirjana and Mihaljevic, Ivan}, year = {2009}, keywords = {Activin A, Inhibin A, Thyroid Papillary and Follicular Carcinomas}, title = {Clinical Implication of Activin A, Inhibin A, and Their Receptors mRNA Expression in Thyroid Papillary and Follicular Carcinomas}, keyword = {Activin A, Inhibin A, Thyroid Papillary and Follicular Carcinomas}, publisherplace = {Barcelona, \v{S}panjolska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font